Human Low-density Lipoprotein-receptor-related Protein 4, LRP-4 ELISA Kit, 96T Drug Development and Evaluation Inhibition of myosin phosphatase leads

Inhibition of myosin phosphatase leads to increased myosin phosphorylation and enhanced smooth muscle contraction

which induces NF-kappaB activation and cell death initiated by LTbeta ligation

These snRNPs are involved in pre-mRNA splicing| and the encoded protein may also play a role in pre-mRNA splicing or snRNP structure

This protein also ubiquitinates the p53 tumor suppressor

This mutation is thought to effect the expression of this gene and it has been proposed that it may be associated with Autistic Spectrum Disorder

Human Low-density Lipoprotein-receptor-related Protein 4, LRP-4 ELISA Kit, 96T Drug Development and Evaluation Inhibition of myosin phosphatase leadsMediates SOST dependent inhibition of bone formation. Functions as a specific facilitator of SOST mediated inhibition of Wnt signaling. Plays a key role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between motor neuron and skeletal muscle. Directly binds AGRIN and recruits it to the MUSK signaling complex. Mediates the AGRIN induced phosphorylation of MUSK, the kinase of the complex. The activation of MUSK in